Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Boehringer Ingelheim Aktiebolag
AB
Active
Org 5561030650
Hammarby Allé 29, 120 32
Stockholm
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1966
72 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Boehringer Ingelheim Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
JG
Jimmy Gustav Almqvist
Chief Auditor
Chief Auditor
2025
MU
Maj Ulrika Henriksson
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2022
Former (3)
MC
Max Christian Schrecklinger
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2014 – 2022
LM
Lars Mikael Käll
Chief Auditor
Chief Auditor
2022 – 2025
AG
Anna Gabriella Hermansson
Chief Auditor
Chief Auditor
2014 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
AA
Angelika Anna Kirchen
Board of Directors
2025
OS
Olof Staffan Gustafsson
Board of Directors
2022
UL
Ulf Lennart Jungersten
Chairman
2025
Former (4)
AL
Amy Louisa Arthur
Chairman
2022 – 2022
PN
Paul Nicholas Dunesky
Chairman
2022 – 2025
FX
Franz Xaver Zinsberger
Chairman
2014 – 2022
MC
Mikael Christian Schwartz
Board of Directors
2014 – 2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
BOEHRINGER INGELHEIM AUSLANDSBETEILIGUNGS GMBH
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Boehringer Ingelheim Aktiebolag
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
